Timber Pharmaceuticals EPS
What is the EPS of Timber Pharmaceuticals?
The EPS of Timber Pharmaceuticals, Inc. is -0.25
What is the definition of EPS?
Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. It is adjusted for dilution and calculated over trailing twelve months.
ttm (trailing twelve months)
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS of companies in the Health Care sector on NYSE compared to Timber Pharmaceuticals
What does Timber Pharmaceuticals do?
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical dermatology company, focused on the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.
Companies with eps similar to Timber Pharmaceuticals
- Condor Petroleum has EPS of -0.25
- TDb Split has EPS of -0.25
- Guyana Gold has EPS of -0.25
- Serko has EPS of -0.25
- Nicco Parks & Resorts has EPS of -0.25
- Shun Tak has EPS of -0.25
- Timber Pharmaceuticals has EPS of -0.25
- Dongfeng Motor has EPS of -0.25
- Pretium Resources has EPS of -0.25
- Libero Copper & Gold has EPS of -0.25
- Maxx Sports TV has EPS of -0.25
- Pretium Resources has EPS of -0.25
- GURU Organic has EPS of -0.25